Today, through its EU Authorized Representative OrthoGrow Distribution, Bodycad received product notification confirmation from the Belgian Federal Agency for Medicines and Health Products in Brussels, the legislative capital for the EU, for its personalized unicompartmental knee system. This enables OrthoGrow and Bodycad to commercially launch this truly personalized orthopaedic restoration within the EU, in accordance with current EU Medical Device Directive for custom devices. Bodycad announced FDA 510k clearance for its personalized unicompartmental knee system earlier this year.
Learn more about the personalized knee at the Bodycad product pages. Comments are closed.
|
Archives
March 2019
Categories
All
|